A new report has revealed that almost a third of British people who recently died with the so-called Delta (Indian) variant of COVID-19 had already received two doses of coronavirus vaccines. Published by Public Health England (PHE), an executive agency of the UK government’s Department of Health and Social Care, the analysis shows that of 42 people who died with the Delta variant, 12 were officially classed as fully vaccinated. Coming at a time when the British public are being urged to volunteer for trials to test whether a third vaccine dose could protect against new variants of the virus, the finding seems likely to be used to promote the idea that regular ‘booster’ doses of the vaccines are now needed.
The PHE analysis also shows that a further 7 of the 42 deaths occurred in people who had received one vaccine dose 21 or more days previously. Single doses of COVID-19 vaccines are claimed to provide at least some protection against the coronavirus. But with the Delta variant reportedly now having spread to 74 countries and expected to become the dominant strain worldwide, the futility of a vaccine-only approach to the pandemic is rapidly becoming apparent. The inevitable mutations that occur as the virus adapts to current COVID-19 vaccines could likely result in the global population being coerced into accepting still further experimental inoculations, potentially even on an annual basis. With many people already understandably concerned about the rapid development and rollout of the current generation of vaccines, such a strategy threatens to expose the global population to increasing health risks.
At the recent G7 meeting held in the UK, leaders of some of the world’s largest pharmaceutical exporting nations issued a declaration in which they plan to reduce the time taken to develop and license future vaccines to under 100 days. Claiming that current COVID-19 vaccines are ‘safe’ – despite being developed in under a year, being based on experimental gene technology and only authorized via ‘emergency use’ mechanisms – the declaration pointedly ignores their lack of long-term safety data. Instead, the roles of the ‘private sector’ and ‘industry representatives’ are explicitly referred to and praised in the document. These terms are both code phrases for the multinational pharmaceutical industry, of course.
As Dr. Rath described in the historic speech he gave in Warsaw, Poland, in 2011, the pharmaceutical industry has a century-long history of placing profit over life. Viewed in this light, the development and ultra-rapid rollout of experimental COVID-19 vaccines simply continues this unethical tradition. Over the past few months there has been growing evidence of serious problems occurring after COVID-19 vaccinations are administered. These include blood clots and other dangerous blood conditions, heart inflammation, and death.
Despite these risks, the total market for COVID-19 vaccines is predicted to be worth $100 billion in sales and $40 billion in post-tax profits. Meanwhile, quietly ignored by the pharma-compliant mainstream media, a US government-funded study recently concluded that the risks of these vaccines are not being adequately disclosed. To the multinational pharmaceutical industry, of course, the non-disclosure of such risks is essential for its continued survival. The discovery that combining vitamin C with other natural compounds impedes key mechanisms of coronavirus infection poses an even greater threat to the industry’s profits. As such, the news that current vaccines are showing signs of becoming ineffective against new variants of the virus will merely be used by drug company executives as an argument for annual booster doses to be given. For in the world of the pharmaceutical ‘business with disease’, the greed-driven interests of drug company investors are always prioritized over human health.